Vancomycin

규격

1404-90-6CAS 번호

215-772-6EC 번호

(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamiIUPAC 명칭

C66H75Cl2N9O24화학식

1449.2 g/mol분자량

VANCOMYCIN; 1404-90-6; Vancomicina; Vancomycine; Vancomycinum; 6Q205EH1VU; DTXSID0042664; CHEBI:28001; Vancocin HCL; Vancomycin Lilly; Sulfate, Vancomycin; RefChem:6345; A07AA09; J01XA01; S01AA28; DTXCID401031367; 215-772-6; (1S,2R,18R,19R,22S,25R,28R,40S)-48-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)-22-(carbamoylmethyl)-5,47-dichloro-2,18,32,35,37-pentahydroxy-19-((2R)-4-methyl-2-(methylamino)pentanamido)-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo(26.14.2.23,6.214,17.18,12.129,33.010,25.034,39)pentaconta-3,5,8,10,12(48),14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid; (1S,2R,18R,19R,22S,25R,28R,40S)-48-((2S,3R,4S,5S,6R)-3-((2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl)oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-(((2R)-4-methyl-2-(methylamino)pentanoyl)amino)-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo(26.14.2.23,6.214,17.18,12.129,33.010,25.034,39)pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid; Vancocine; Vancomycin EP Impurity I; CHEMBL262777; MFCD05664587; C66H75Cl2N9O24; Vancomycin ( >85%); Vancomycin (USP); Vancomycine [INN-French]; Vancomycinum [INN-Latin]; Vancomicina [INN-Spanish]; HSDB 3262; EINECS 215-772-6; vancomicin; vanomycin; UNII-6Q205EH1VU; Vancomycin [USP:INN:BAN]; Vancomycin hydrochloride from Streptomyces orientalis; Viomycin derivative; [(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-(2-amino-2-oxo-ethyl)-dichloro-pentahydroxy-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-pentaoxo-[?]carboxylic acid; Vancomycin Impurity M; Vancomycin (Standard); Glycopeptide Antibiotic; C06689; D00212; VANCOMYCIN [MI]; VANCOMYCIN [INN]; Prestwick0_000497; Prestwick1_000497; Prestwick2_000497; VANCOMYCIN [HSDB]; SCHEMBL3177; VANCOMYCIN [MART.]; VANCOMYCIN [WHO-DD]; Chloroorienticin B derivative; Lopac0_001267; N-demethylvancomycin derivative; SPBio_002314; orb1298753; CHEMBL3735877; SCHEMBL25297175; SCHEMBL29359312; SCHEMBL29360808; VANCOMYCIN [ORANGE BOOK]; GTPL10932; HY-B0671R; VANCOMYCIN [USP IMPURITY]; VANCOMYCIN [USP MONOGRAPH]; HY-B0671; MSK14018; BDBM50335519; s5784; AKOS030526092; CCG-205340; CS-3242; DB00512; SDCCGSBI-0051233.P002; NCGC00162383-04; NCGC00162383-10; NCGC00162383-11; FV152644; SY389052; NS00001544; 4-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole; Q424027; SR-01000076194-5; BRD-K91065602-001-01-8; BRD-K91065602-003-04-8; BRD-K91065602-003-05-5; (2.2Sp,3.5Sa,2.6Sp)-O4.2,C3.4:C5.4,O4.6:C3.5,C2.7-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]; (S)-3,6-Diamino-hexanoic acid {(3S,9S,12S,15S)-3-((S)-6-hydroxy-2-imino-hexahydro-pyrimidin-4-yl)-9,12-bis-hydroxymethyl-2,5,8,11,14-pentaoxo-6-[1-ureido-meth-(Z)-ylidene]-1,4,7,10,13pentaaza-cyclohexadec-15-yl}-amide; Vancomycin base동의어